We address health conditions like high blood pressure, diabetes, and thyroid issues through comprehensive exams, EKGs, labs, nutrition guidance, and FDA approved GLP-1 medications such as semaglutide
It states the provider must verify eligibility before any transition is planned, rather than treating the switch as a scheduling matter
For this to happen, we need to prove efficacy and safety in clinical trials that are specifically designed to investigate these outcomes. Why Might Weight Loss and Diabetes Drugs Lower Alcohol Cravings
Any use of GLP-1 receptor agonists for PCOS should involve shared decision-making between patient and clinician, with clear discussion of the off-label nature of treatment and monitoring requirements
Medicare Part D does not currently cover these for weight loss alone